DO NOW
100
Flagship intelligence / adoption product
ACCESS + TEMPO Adoption Pathway Intelligence
Create the definitive live map of TEMPO participants, ACCESS organizations, clinical-use areas, intended uses, evidence requirements, payment mechanics, referral workflows, outcomes and regulatory changes.
Users: digital-health manufacturers, ACCESS organizations, health systems, payers, investors, policy teams
P4L could produce: living Decision Atlas, participant/company profiles, pathway readiness diagnostic, weekly change brief, evidence-to-payment map
Trigger signals: SIG-2026-001 · SIG-2026-002 · SIG-2026-003 · SIG-2026-004
DO NOW
100
Readiness diagnostic + intelligence product
Medicare App Library Readiness Navigator
Turn CMS's multi-step app-library requirements into a readiness path covering identity, CMS Aligned Networks, FHIR, evidence, privacy/security, usability/equity, DiMe/CARIN evaluation and ACCESS interactions.
Users: digital-health apps, conversational AI vendors, diabetes/obesity platforms, health systems, investors
P4L could produce: eligibility/readiness assessment, evidence gap map, partner dependency map, application checklist, change alerts
Trigger signals: SIG-2026-012 · SIG-2026-013 · SIG-2026-014 · SIG-2026-026
DO NOW
98
Standard + readiness lab
Clinical Agentic AI Adoption & Control Standard
Define evidence, autonomy boundaries, escalation, monitoring, interoperability, post-deployment safety, governance and institutional adoption requirements for clinically consequential agents.
Users: health systems, clinical AI developers, federal programs, payers, investors
P4L could produce: agent authority matrix, clinical adoption standard, overseer/monitoring requirements, deployment diagnostic, policy watch
Trigger signals: SIG-2026-017 · SIG-2026-024 · SIG-2026-010 · SIG-2026-013
DO NOW
96
Healthspan evidence + commercialization observatory
PROSPR Healthspan Translation Observatory
Track healthspan endpoints, biomarkers, trial architecture, interventions, regulatory interactions and commercialization implications across PROSPR projects.
Users: healthspan companies, researchers, investors, health systems, policy teams
P4L could produce: endpoint tracker, trial/award graph, claim-readiness map, commercialization watch, healthspan evidence brief
Trigger signals: SIG-2026-005 · SIG-2026-006 · SIG-2026-007 · SIG-2026-020
DO NOW
95
Data/infrastructure adoption product
AI-Ready Health Data & Interoperability Readiness Map
Map USCDI v7, HTI-5, FHIR, CMS Aligned Networks, identity and app requirements into the minimum data/infrastructure conditions for AI-enabled care and prevention.
Users: AI developers, digital-health companies, health systems, EHR/integration teams, payers
P4L could produce: data readiness diagnostic, standards crosswalk, agent/data access map, implementation watch, stale-standard alerts
Trigger signals: SIG-2026-013 · SIG-2026-014 · SIG-2026-024 · SIG-2026-026
PREPARE
88
Evidence-to-adoption service/product
Real-Time Evidence Generation Readiness Sprint
Help digital-health and life-science teams align digital measures, trial data flows, evidence claims and regulatory decision needs with FDA's evolving DHT and real-time trial direction.
Users: DHT developers, biopharma, trial sponsors, research platforms
P4L could produce: evidence architecture, endpoint/measure readiness, data-flow map, regulatory question set, trial-to-adoption plan
Trigger signals: SIG-2026-015 · SIG-2026-016 · SIG-2026-021
PREPARE
87
Scenario + adoption diagnostic
CY 2027 RPM/RTM Business-Model Stress Test
Model how proposed initiating-visit, staffing, contractor and bundling changes could alter RPM/RTM economics, compliance and delivery design.
Users: RPM/RTM vendors, medical groups, digital-health investors, health systems
P4L could produce: scenario model, risk flags, operating-model redesign options, final-rule alert, buyer/economic case
Trigger signals: SIG-2026-008 · SIG-2026-025
PREPARE
86
Market/adoption intelligence
Authorized AI Device → Real Adoption Tracker
Connect FDA authorization to evidence, implementation, health-system adoption, workflow fit, postmarket performance and reimbursement—showing which AI devices actually cross the adoption gap.
Users: health systems, AI developers, investors, payers
P4L could produce: authorization/adoption database, adoption-gap score, postmarket evidence tracker, buyer map
Trigger signals: SIG-2026-010 · SIG-2026-023
PREPARE
83
Research-to-adoption intelligence
IGoR / AI-Native Biomedical Research Translation Watch
Track whether AI-orchestrated hypothesis generation, experimental protocols, lab marketplaces and model feedback loops produce validated speed/reproducibility gains and new translation bottlenecks.
Users: research institutions, biotech, AI labs, funders
P4L could produce: program/award graph, validated 10× benchmark watch, protocol/interoperability map, translation implications
Trigger signals: SIG-2026-018
PREPARE
83
Convening intelligence / thought leadership
Geroscience 2026 Agenda-to-Action Briefing
Build a pre-summit issue map and post-summit evidence/consensus delta identifying what changed in geroscience priorities, endpoints, translation and health focus.
Users: researchers, healthspan companies, policy teams, media, investors
P4L could produce: pre-summit agenda map, live watchlist, post-summit delta, policy/adoption implications
Trigger signals: SIG-2026-011